BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18217914)

  • 1. De novo membranous nephropathy associated with donor-specific alloantibody.
    El Kossi M; Harmer A; Goodwin J; Wagner B; Shortland J; Angel C; McKane W
    Clin Transplant; 2008; 22(1):124-7. PubMed ID: 18217914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
    Seveso M; Bosio E; Ancona E; Cozzi E
    Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant de novo membranous nephropathy in childhood.
    Sebire NJ; Bockenhauer D
    Fetal Pediatr Pathol; 2005; 24(2):95-103. PubMed ID: 16243754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
    Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
    Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membranous glomerulonephritis may be associated with heavy marijuana abuse.
    Bohatyrewicz M; Urasinska E; Rozanski J; Ciechanowski K
    Transplant Proc; 2007 Dec; 39(10):3054-6. PubMed ID: 18089320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria following transplantation. Correlation with histopathology and outcome.
    First MR; Vaidya PN; Maryniak RK; Weiss MA; Munda R; Fidler JP; Penn I; Alexander JW
    Transplantation; 1984 Dec; 38(6):607-12. PubMed ID: 6390821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological analysis of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Shirakawa H; Omoto K; Tsunoyama K; Iida S; Tanabe K; Yamaguchi Y
    Clin Transplant; 2009 Aug; 23 Suppl 20():39-43. PubMed ID: 19594595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of living-related renal transplant from the donor with membranous nephropathy.
    Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakai K; Sakamoto S; Urasaki K; Yanagisawa A; Fukatsu A; Yoshimura N
    Clin Transplant; 2009 Aug; 23 Suppl 20():62-6. PubMed ID: 19594600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent and de novo membranous glomerulonephritis in renal cadaver allotransplants.
    Briner J; Binswanger U; Largiadèr F
    Clin Nephrol; 1980 Apr; 13(4):189-96. PubMed ID: 6991185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of proteinuria in renal transplant recipients developing de novo human leukocyte antigen antibodies.
    Fotheringham J; Angel C; Goodwin J; Harmer AW; McKane WS
    Transplantation; 2011 May; 91(9):991-6. PubMed ID: 21519315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranous glomerulopathy following kidney transplantation. Association with renal vein thrombosis in two of nine cases.
    First MR; Mendoza N; Maryniak RK; Weiss MA
    Transplantation; 1984 Dec; 38(6):603-7. PubMed ID: 6390820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.
    Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD
    Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo membranous nephropathy (MN) in kidney allografts. A peculiar form of alloimmune disease?
    Ponticelli C; Glassock RJ
    Transpl Int; 2012 Dec; 25(12):1205-10. PubMed ID: 22909324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X; Ishida H; Yamaguchi Y; Tanabe K
    Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrence of de novo membranous glomerulonephritis and recurrent IgA nephropathy in a renal allograft.
    Pindur J; Mosheim MB; Giron MA; Guerriero WG; Suki W; Truong L
    Clin Nephrol; 1994 Oct; 42(4):269-72. PubMed ID: 7834922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in donor-specific alloantibody production after transplantation.
    Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2715-7. PubMed ID: 18021966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts.
    Monga G; Mazzucco G; Basolo B; Quaranta S; Motta M; Segoloni G; Amoroso A
    Mod Pathol; 1993 May; 6(3):249-58. PubMed ID: 8346172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An attempt to extend the donor criteria for successful living-related kidney transplantation from a donor with membranous nephropathy.
    Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakamoto S; Yoshimura N
    Transplant Proc; 2009; 41(1):446-9. PubMed ID: 19249577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["De novo" glomerulonephritis in the transplanted kidney].
    Stefanov G; Beleva B; Simeonov P; Minkova V; Anastasov G
    Vutr Boles; 1989; 28(2):85-7. PubMed ID: 2669343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.